← FDA DRUG APPROVALS
FDA ANDA · ANDA207585
RHUZDAH
norethindrone and ethinyl estradiol tablet
Sponsor: AUROBINDO PHARMA
APPLICATION
ANDA207585
TYPE
ANDA
ORIGINAL APPROVAL
2022-10-11
LATEST ACTION
2022-10-11
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
RHUZDAHDiscontinued
ETHINYL ESTRADIOL 0.035MG, NORETHINDRONE 0.4MG · TABLET · ORAL-28
Approval history
2022-10-11UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.